文献速递母胎医学

亚洲、澳大利亚、欧洲和美国无创产前检测中性染色体纳入情况的调查研究

Inclusion of sex chromosomes in noninvasive prenatal testing in Asia, Australia, Europe and the USA: A survey study.
PubMed 文献 · Prenat Diagn · 2023-02-07

该调查研究通过邮件向亚洲、澳大利亚、欧洲和美国的胎儿医学与临床遗传学专家发放问卷,了解无创产前检测(NIPT)中性染色体纳入及胎儿染色体性别与性染色体异常(SCA)的报告实践,并更新NIPT的总体实施情况。结果显示多数国家已有NIPT指南,但并非所有指南涉及胎儿性别及SCA报告;多数地区NIPT常纳入性染色体,报告实践多样且多未被指南覆盖,NIPT实施程度因地区而异。

要点

  • 多数纳入国家已有NIPT指南,但并非所有指南涉及胎儿染色体性别和SCA的报告。
  • 多数地区NIPT常纳入性染色体,通常在默认情况下或父母希望知晓胎儿性别时进行。
  • 多数地区SCA报告方式为给出「低」或「高」风险表述和/或命名SCA,报告实践多样且多未被指南覆盖。

核心结论

  • 在多数被研究的国家/州,NIPT常纳入性染色体,胎儿染色体性别和SCA的报告实践多样且最常未被指南涉及,NIPT总体实施程度因国家/州而异。

研究设计与样本

  • 通过邮件向亚洲、澳大利亚、欧洲和美国的胎儿医学与临床遗传学专家发放针对研究目标的问卷。

主要发现

  • 多数纳入国家已有NIPT指南,但并非所有现有指南涉及胎儿染色体性别和SCA的报告。
  • 在多数地区NIPT常纳入性染色体(五个澳大利亚州、中国、香港、以色列、新加坡、泰国、美国以及31个欧洲国家中的23个),最常通过默认方式或父母希望知晓胎儿性别时进行。
  • 在多数地区,潜在SCA的报告方式为给出其风险「低」或「高」和/或命名SCA。
  • 据三个澳大利亚州、中国、以色列、新加坡、泰国以及31个欧洲国家中24个的受访者,不足50%的孕妇接受NIPT,但该比例、NIPT的基因组覆盖范围及其作为初级或次级筛查的应用因地区而异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the extent to which sex chromosomes are included in current noninvasive prenatal testing (NIPT) and the reporting practices with respect to fetal chromosomal sex and sex chromosome aberrations (SCAs), in addition to an update on the general implementation of NIPT. METHOD: A questionnaire addressing the research objectives was distributed by email to fetal medicine and clinical genetics experts in Asia, Australia, Europe and the USA. RESULTS: Guidelines on NIPT are available in the majority of the included countries. Not all existing guidelines address reporting of fetal chromosomal sex and SCAs. In most settings, NIPT frequently includes sex chromosomes (five Australian states, China, Hong Kong, Israel, Singapore, Thailand, USA and 23 of 31 European countries). This occurs most often by default or when parents wish to know fetal sex. In most settings, a potential SCA is reported by stating the risk hereof as "low" or "high" and/or by naming the SCA. Less than 50% of all pregnant women receive NIPT according to respondents from three Australian states, China, Israel, Singapore, Thailand and 24 of 31 European countries. However, this percentage, the genomic coverage of NIPT and its application as primary or secondary screening vary by setting. CONCLUSION: In most of the studied countries/states, NIPT commonly includes sex chromosomes. The reporting practices concerning fetal chromosomal sex and SCAs are diverse and most commonly not addressed by guidelines. In general, NIPT is variably implemented across countries/states.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Steffensen EH, Skakkebaek A, Gadsbøll K, et al. Inclusion of sex chromosomes in noninvasive prenatal testing in Asia, Australia, Europe and the USA: A survey study. Prenat Diagn. 2023. PMID: 36703254. doi:10.1002/pd.6322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。